Cargando…

Effect of COPD severity and comorbidities on the result of the PHQ-9 tool for the diagnosis of depression: results from the COSYCONET cohort study

The diagnosis of depression, a frequent comorbidity of chronic obstructive pulmonary disease (COPD), is often supported by questionnaires, such as the Patient Health Questionnaire 9 (PHQ-9). It is unknown to which extent its single questions are affected by the clinical characteristics of COPD patie...

Descripción completa

Detalles Bibliográficos
Autores principales: von Siemens, Sarah Marietta, Jörres, Rudolf A., Behr, Jürgen, Alter, Peter, Lutter, Johanna, Lucke, Tanja, Söhler, Sandra, Welte, Tobias, Watz, Henrik, Vogelmeier, Claus F., Trudzinski, Franziska, Rief, Winfried, Herbig, Britta, Kahnert, Kathrin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6371561/
https://www.ncbi.nlm.nih.gov/pubmed/30744630
http://dx.doi.org/10.1186/s12931-019-0997-y
_version_ 1783394578146000896
author von Siemens, Sarah Marietta
Jörres, Rudolf A.
Behr, Jürgen
Alter, Peter
Lutter, Johanna
Lucke, Tanja
Söhler, Sandra
Welte, Tobias
Watz, Henrik
Vogelmeier, Claus F.
Trudzinski, Franziska
Rief, Winfried
Herbig, Britta
Kahnert, Kathrin
author_facet von Siemens, Sarah Marietta
Jörres, Rudolf A.
Behr, Jürgen
Alter, Peter
Lutter, Johanna
Lucke, Tanja
Söhler, Sandra
Welte, Tobias
Watz, Henrik
Vogelmeier, Claus F.
Trudzinski, Franziska
Rief, Winfried
Herbig, Britta
Kahnert, Kathrin
author_sort von Siemens, Sarah Marietta
collection PubMed
description The diagnosis of depression, a frequent comorbidity of chronic obstructive pulmonary disease (COPD), is often supported by questionnaires, such as the Patient Health Questionnaire 9 (PHQ-9). It is unknown to which extent its single questions are affected by the clinical characteristics of COPD patients. We addressed this question in 2255 GOLD grade 1–4 patients from the COSYCONET (COPD and Systemic Consequences - Comorbidities Network) COPD cohort. The dependence on COPD severity was assessed using symptoms, exacerbation risk (GOLD A-D; modified Medical Research Council dyspnoea scale (mMRC)), and frequent comorbidities as predictors of PHQ-9 results, while including age, gender, body mass index (BMI) and smoking habits as covariates. Symptoms and exacerbation risk were associated with depression in an additive manner, with mean elevations in the PHQ-9 sum score by 2.75 and 1.44 points, respectively. Asthma, sleep apnoea, gastrointestinal disorders, osteoporosis and arthritis were linked to increases by 0.8 to 1.3 points. Overall, the COPD characteristics contributed to the mean PHQ-9 score by increases from 4.5 or 5.2 to 6.3 points, respectively, when either taking GOLD A as reference or the absence of comorbidities. This finding was independent of the diagnosis of mental disorder or the intake of antidepressants. The presence of COPD led to an increase in the proportion of scores indicating depression from 12 to 22%. Single item analysis revealed homogenous effects regarding GOLD groups, but heterogeneous effects regarding GOLD grades. These findings indicate specific effects of COPD severity on the PHQ-9 depression score, especially symptoms and exacerbation risk, explaining the high prevalence of depression in COPD. Alternative explanations like an overlap of COPD severity and PHQ-9 items are discussed. Of note, we also found COPD treatment effects on depression scores. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12931-019-0997-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6371561
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-63715612019-02-21 Effect of COPD severity and comorbidities on the result of the PHQ-9 tool for the diagnosis of depression: results from the COSYCONET cohort study von Siemens, Sarah Marietta Jörres, Rudolf A. Behr, Jürgen Alter, Peter Lutter, Johanna Lucke, Tanja Söhler, Sandra Welte, Tobias Watz, Henrik Vogelmeier, Claus F. Trudzinski, Franziska Rief, Winfried Herbig, Britta Kahnert, Kathrin Respir Res Research The diagnosis of depression, a frequent comorbidity of chronic obstructive pulmonary disease (COPD), is often supported by questionnaires, such as the Patient Health Questionnaire 9 (PHQ-9). It is unknown to which extent its single questions are affected by the clinical characteristics of COPD patients. We addressed this question in 2255 GOLD grade 1–4 patients from the COSYCONET (COPD and Systemic Consequences - Comorbidities Network) COPD cohort. The dependence on COPD severity was assessed using symptoms, exacerbation risk (GOLD A-D; modified Medical Research Council dyspnoea scale (mMRC)), and frequent comorbidities as predictors of PHQ-9 results, while including age, gender, body mass index (BMI) and smoking habits as covariates. Symptoms and exacerbation risk were associated with depression in an additive manner, with mean elevations in the PHQ-9 sum score by 2.75 and 1.44 points, respectively. Asthma, sleep apnoea, gastrointestinal disorders, osteoporosis and arthritis were linked to increases by 0.8 to 1.3 points. Overall, the COPD characteristics contributed to the mean PHQ-9 score by increases from 4.5 or 5.2 to 6.3 points, respectively, when either taking GOLD A as reference or the absence of comorbidities. This finding was independent of the diagnosis of mental disorder or the intake of antidepressants. The presence of COPD led to an increase in the proportion of scores indicating depression from 12 to 22%. Single item analysis revealed homogenous effects regarding GOLD groups, but heterogeneous effects regarding GOLD grades. These findings indicate specific effects of COPD severity on the PHQ-9 depression score, especially symptoms and exacerbation risk, explaining the high prevalence of depression in COPD. Alternative explanations like an overlap of COPD severity and PHQ-9 items are discussed. Of note, we also found COPD treatment effects on depression scores. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12931-019-0997-y) contains supplementary material, which is available to authorized users. BioMed Central 2019-02-11 2019 /pmc/articles/PMC6371561/ /pubmed/30744630 http://dx.doi.org/10.1186/s12931-019-0997-y Text en © The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
von Siemens, Sarah Marietta
Jörres, Rudolf A.
Behr, Jürgen
Alter, Peter
Lutter, Johanna
Lucke, Tanja
Söhler, Sandra
Welte, Tobias
Watz, Henrik
Vogelmeier, Claus F.
Trudzinski, Franziska
Rief, Winfried
Herbig, Britta
Kahnert, Kathrin
Effect of COPD severity and comorbidities on the result of the PHQ-9 tool for the diagnosis of depression: results from the COSYCONET cohort study
title Effect of COPD severity and comorbidities on the result of the PHQ-9 tool for the diagnosis of depression: results from the COSYCONET cohort study
title_full Effect of COPD severity and comorbidities on the result of the PHQ-9 tool for the diagnosis of depression: results from the COSYCONET cohort study
title_fullStr Effect of COPD severity and comorbidities on the result of the PHQ-9 tool for the diagnosis of depression: results from the COSYCONET cohort study
title_full_unstemmed Effect of COPD severity and comorbidities on the result of the PHQ-9 tool for the diagnosis of depression: results from the COSYCONET cohort study
title_short Effect of COPD severity and comorbidities on the result of the PHQ-9 tool for the diagnosis of depression: results from the COSYCONET cohort study
title_sort effect of copd severity and comorbidities on the result of the phq-9 tool for the diagnosis of depression: results from the cosyconet cohort study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6371561/
https://www.ncbi.nlm.nih.gov/pubmed/30744630
http://dx.doi.org/10.1186/s12931-019-0997-y
work_keys_str_mv AT vonsiemenssarahmarietta effectofcopdseverityandcomorbiditiesontheresultofthephq9toolforthediagnosisofdepressionresultsfromthecosyconetcohortstudy
AT jorresrudolfa effectofcopdseverityandcomorbiditiesontheresultofthephq9toolforthediagnosisofdepressionresultsfromthecosyconetcohortstudy
AT behrjurgen effectofcopdseverityandcomorbiditiesontheresultofthephq9toolforthediagnosisofdepressionresultsfromthecosyconetcohortstudy
AT alterpeter effectofcopdseverityandcomorbiditiesontheresultofthephq9toolforthediagnosisofdepressionresultsfromthecosyconetcohortstudy
AT lutterjohanna effectofcopdseverityandcomorbiditiesontheresultofthephq9toolforthediagnosisofdepressionresultsfromthecosyconetcohortstudy
AT lucketanja effectofcopdseverityandcomorbiditiesontheresultofthephq9toolforthediagnosisofdepressionresultsfromthecosyconetcohortstudy
AT sohlersandra effectofcopdseverityandcomorbiditiesontheresultofthephq9toolforthediagnosisofdepressionresultsfromthecosyconetcohortstudy
AT weltetobias effectofcopdseverityandcomorbiditiesontheresultofthephq9toolforthediagnosisofdepressionresultsfromthecosyconetcohortstudy
AT watzhenrik effectofcopdseverityandcomorbiditiesontheresultofthephq9toolforthediagnosisofdepressionresultsfromthecosyconetcohortstudy
AT vogelmeierclausf effectofcopdseverityandcomorbiditiesontheresultofthephq9toolforthediagnosisofdepressionresultsfromthecosyconetcohortstudy
AT trudzinskifranziska effectofcopdseverityandcomorbiditiesontheresultofthephq9toolforthediagnosisofdepressionresultsfromthecosyconetcohortstudy
AT riefwinfried effectofcopdseverityandcomorbiditiesontheresultofthephq9toolforthediagnosisofdepressionresultsfromthecosyconetcohortstudy
AT herbigbritta effectofcopdseverityandcomorbiditiesontheresultofthephq9toolforthediagnosisofdepressionresultsfromthecosyconetcohortstudy
AT kahnertkathrin effectofcopdseverityandcomorbiditiesontheresultofthephq9toolforthediagnosisofdepressionresultsfromthecosyconetcohortstudy
AT effectofcopdseverityandcomorbiditiesontheresultofthephq9toolforthediagnosisofdepressionresultsfromthecosyconetcohortstudy